Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Creative Medical Technology Holdings (CELZ) Revenue (2017 - 2025)

Creative Medical Technology Holdings (CELZ) has disclosed Revenue for 10 consecutive years, with $3000.0 as the latest value for Q1 2025.

  • On a quarterly basis, Revenue changed N/A to $3000.0 in Q1 2025 year-over-year; TTM through Sep 2025 was $6000.0, a 45.45% decrease, with the full-year FY2024 number at $11000.0, up 22.22% from a year prior.
  • Revenue was $3000.0 for Q1 2025 at Creative Medical Technology Holdings, roughly flat from $3000.0 in the prior quarter.
  • In the past five years, Revenue ranged from a high of $67754.0 in Q4 2021 to a low of $3000.0 in Q4 2023.
  • A 5-year average of $18123.1 and a median of $10000.0 in 2021 define the central range for Revenue.
  • Peak YoY movement for Revenue: surged 450.0% in 2022, then crashed 89.09% in 2023.
  • Creative Medical Technology Holdings' Revenue stood at $67754.0 in 2021, then plummeted by 72.55% to $18600.0 in 2022, then tumbled by 83.87% to $3000.0 in 2023, then changed by 0.0% to $3000.0 in 2024, then changed by 0.0% to $3000.0 in 2025.
  • Per Business Quant, the three most recent readings for CELZ's Revenue are $3000.0 (Q1 2025), $3000.0 (Q4 2024), and $8000.0 (Q2 2024).